Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

19 Results

Guidelines and Advice

Optimal Systemic Therapy for Early Female Breast Cancer

Status: In-Review
ID: 1-21

Sep 2014

Guidelines and Advice

Organizational Guideline for Gynecologic Oncology Services in Ontario

Status: In-Review
ID: 4-11

Dec 1969

Guidelines and Advice

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Guidelines and Advice

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Status: In-Review
ID: 2-11
Version: 4

Dec 1969

Guidelines and Advice

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Status: Archived
ID: CED 21

Jan 2011

Guidelines and Advice

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

Status: In-Review
ID: 4-5

Dec 1969

Guidelines and Advice

Patient Safety Issues: Key Components of Intravenous Systemic Cancer Therapy Labelling

Status: Current
ID: 12-11
Version: 2

Dec 1969

Guidelines and Advice

Oral Capecitabine (Xeloda™) in the First-line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-15

Sep 2011

Guidelines and Advice

Postoperative Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer: Guidance for Nurses

Status: Archived
ID: 7-1-2N

Dec 1969

Guidelines and Advice

Optimal Treatment Strategies for Localized Ewing's Sarcoma of Bone after Neoadjuvant Chemotherapy

Status: Current
ID: 11-6
Version: 2

Dec 1969

Guidelines and Advice

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Status: In-Review
ID: 2-4
Version: 3

Mar 2019

Guidelines and Advice

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Status: Current
ID: GL-C50-27

Nov 2021

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Optimal Systemic Therapy for Early Female Breast Cancer

Organizational Guideline for Gynecologic Oncology Services in Ontario

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

Patient Safety Issues: Key Components of Intravenous Systemic Cancer Therapy Labelling

Oral Capecitabine (Xeloda™) in the First-line Treatment of Metastatic Colorectal Cancer

Postoperative Adjuvant Chemotherapy in Completely Resected Non-Small Cell Lung Cancer: Guidance for Nurses

Optimal Treatment Strategies for Localized Ewing's Sarcoma of Bone after Neoadjuvant Chemotherapy

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

Pages